Fig. 5
The correlational analysis between miRNA-338-3p, miRNA-1250-5p, and miRNA-3065-5p groups. E: Experimental group, C: Control group. (A–C) Illustrate the correlations between miRNA-338-3p, miRNA-1250-5p, and miRNA-3065-5p in the experimental group, while (D–F) depict these correlations in the overall population. (A) In the experimental group, miRNA-338-3p was positively correlated with miRNA-1250-5p (r = 0.381, p < 0.001). (B) In the experimental group, miRNA-338-3p was positively correlated with miRNA-3065-5p (r = 0.422, p < 0.001). (C) In the experimental group, miRNA-1250-5p was positively correlated with miRNA-3065-5p (r = 0.531, p < 0.001). (D) In the experimental group, miRNA-338-3p was positively correlated with miRNA-1250-5p. In the control group, miRNA-338-3p was negatively correlated with miRNA-1250-5p, while a positive correlation was observed in the total population (r = 0.234, p = 0.007). (E) miRNA-338-3p positively correlated with miRNA-3065-5p in the experimental, control group, and total population (r = 0.356, p < 0.001). (F) miRNA-1250-5p was positively correlated with miRNA-3065-5p in the experimental group, control group, and total population (r = 0.452, p < 0.001).
